+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Single-cell Omics Market Size, Share & Trends Analysis Report By Product Type (Single-cell Genomics, Single-cell Transcriptomics), By Application (Oncology, Neurology), By End-User, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • May 2023
  • Region: Global
  • Grand View Research
  • ID: 5830895
Description Jump to:
The global single-cell omics market size is expected to reach USD 4.64 billion by 2030, expanding at 16.1% CAGR from 2023 to 2030. The increasing significance of single-cell omics in cell therapy, reproductive medicine, and personalized medicine are some of the key drivers for the market. In addition, increasing industry-academia collaborations are accelerating the adoption of single-cell omics technology in research & development. Similarly, supportive government legislation, rising funding for research, and various developments undertaken by market players are further contributing to the market expansion.

The rising demand for personalized medicine and growing adoption of omics-based tools to foster personalized medicine research are anticipated to cater to market demand throughout the forecast period. In addition, ongoing research efforts to explore the value of personalized medicine to develop targeted therapies tailored to the needs of individual patients have gained traction in past years. Thus, the evolution of precision medicine is pushing manufacturers to develop omics-based models for respective conditions. For instance, in January 2021 Mission Bio, Inc. launched Tapestri-a single cell multi-omics system for faster development of precision cancer therapies.

Single-cell-based omics have found a large range of applications in genetic engineering and cellular biology studies. This has allowed scientists to analyze cell lineage, identify cell types, and investigate cellular differentiation pathways, which has created huge traction for regenerative medicine and drug development processes. Thus, an emerging application of single-cell omics in the drug development process is anticipated to support the global market. For instance, in January 2021 Vizgen launched Pharma Accelerator Lab in response to the higher demand from top pharmaceutical companies who are incorporating single cellular & spatial transcriptomics solutions to bolster their drug development pipeline.

Furthermore, various organic and inorganic developments undertaken by participants, and increasing industry-academia collaborations have driven global market growth to a significant extent. For instance, in December 2022, 10x Genomics, Inc. announced the launch of its Xenium platform for in-situ analysis. In addition, in June 2022 Fluent BioSciences launched two novel products for 3 single cells RNA analyses. The newly launched T2 and T20 kits allowed scientists to immediately access the power of single-cell transcriptomics with relatively little capital investment.

Single-cell Omics Market Report Highlights

  • By product type, the single-cell genomics segment dominated the market with a share of 45.8% in 2022, due to evolving demand from a wide range of end-users, potential clinical applications of single cells genomics platform, and technological advancements
  • By application, the oncology segment dominated the industry with a share of 55.1% in 2022, due to the rising burden of cancer globally, rapid evolution in single cells analysis techniques, and rising adoption of omics-based tools to study cancer progression
  • Based on end-user, academic, and research organizations segment dominated the market with a share of 42.8% in 2022. The high growth of the segment is attributed to the rising usage of technology on college campuses, increasing research efforts to develop novel modeling tools, and rising research studies by various research institutes to explore diverse applications of cell biology
  • North America established a strong regional position in the global market with a 46.37% share in 2022 due to its highly developed healthcare infrastructure and favorable government policies

Table of Contents

Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Information Or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Technological Advancements in single-cell analysis products
3.2.1.2. Increasing R&D spending by biopharmaceutical and biotechnology companies
3.2.1.3. Increasing trend for personalized medicine
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of single-cell analysis
3.2.2.2. Issues associated with data security and privacy
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Type Business Analysis
4.1. Single-Cell Omics Market: Product Type Movement Analysis
4.2. Single-Cell Genomics
4.2.1. Single-Cell Genomics Market, 2018 - 2030 (USD Million)
4.3. Single-Cell Transcriptomics
4.3.1. Single-Cell Transcriptomics Market, 2018 - 2030 (USD Million)
4.4. Single-Cell Proteomics
4.4.1. Single-Cell Proteomics Market, 2018 - 2030 (USD Million)
4.5. Single-Cell Metabolomics
4.5.1. Single-Cell Metabolomics Market, 2018 - 2030 (USD Million)
Chapter 5. Application Business Analysis
5.1. Single-Cell Omics Market: Application Movement Analysis
5.2. Oncology
5.2.1. Oncology Market, 2018 - 2030 (USD Million)
5.3. Cell Biology
5.3.1. Cell Biology Market, 2018 - 2030 (USD Million)
5.4. Neurology
5.4.1. Neurology Market, 2018 - 2030 (USD Million)
5.5. Immunology
5.5.1. Immunology Market, 2018 - 2030 (USD Million)
Chapter 6. End-User Business Analysis
6.1. Single-Cell Omics Market: End-User Movement Analysis
6.2. Academic and Research Organizations
6.2.1. Academic and Research Organizations Market, 2018 - 2030 (USD Million)
6.3. Pharmaceutical & Biotechnology Companies
6.3.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
6.4. Hospital and Diagnostic Laboratories
6.4.1. Hospital and Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Single-Cell Omics Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.2.3. The U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. U.S. Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Target Disease Prevalence
7.2.4.3. Competitive Scenario
7.2.4.4. Canada Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.3.3. UK
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. UK Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.3.4. Germany
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Germany Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. France Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Italy Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.3.7. Spain
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Spain Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.3.8. Denmark
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Denmark Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.3.9. Sweden
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Sweden Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.3.10. Norway
7.3.10.1. Key Country Dynamics
7.3.10.2. Target Disease Prevalence
7.3.10.3. Competitive Scenario
7.3.10.4. Norway Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. SWOT Analysis
7.4.2. Asia Pacific Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Japan Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.4.4. China
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. China Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. India Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Australia Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Thailand Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.4.8. South Korea
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. South Korea Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.5.3. Brazil
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Brazil Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Mexico Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.5.5. Argentina
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Argentina Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. SWOT Analysis
7.6.2. MEA Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.6.3. South Africa
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. South Africa Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.6.4. Saudi Arabia
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Saudi Arabia Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.6.5. UAE
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. UAE Single-Cell Omics Market, 2018 - 2030 (USD Million)
7.6.6. Kuwait
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Competitive Scenario
7.6.6.4. Kuwait Single-Cell Omics Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. CYTENA GmbH
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. 10x Genomics
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. BD
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. CELLENION
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. PerkinElmer Inc.
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. ANGLE plc
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Illumina, Inc.
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Bio-Rad Laboratories, Inc.
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Mission Bio
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Standard BioTools Inc.
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of abbreviations
Table 2 Global single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 3 Global single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 4 Global single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 5 Global single-cell omics market, by region, 2018 - 2030 (USD Million)
Table 6 North America single-cell omics market, by country, 2018 - 2030 (USD Million)
Table 7 North America single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 8 North America Whole exome sequencing market, by application, 2018 - 2030 (USD Million)
Table 9 North America Whole exome sequencing market, by end-user, 2018 - 2030 (USD Million)
Table 10 U.S. single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 11 U.S. single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 12 U.S. single-cell omics Market, by end-user, 2018 - 2030 (USD Million)
Table 13 Canada single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 14 Canada single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 15 Canada single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 16 Europe single-cell omics market, by country, 2018 - 2030 (USD Million)
Table 17 Europe single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 18 Europe single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 19 Europe single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 20 UK single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 21 UK single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 22 UK single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 23 Germany single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 24 Germany single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 25 Germany single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 26 France single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 27 France single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 28 France single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 29 Italy single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 30 Italy single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 31 Italy single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 32 Spain single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 33 Spain single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 34 Spain single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 35 Denmark single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 36 Denmark single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 37 Denmark single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 38 Sweden single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 39 Sweden single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 40 Sweden single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 41 Norway single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 42 Norway single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 43 Norway single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 44 Asia Pacific single-cell omics market, by country, 2018 - 2030 (USD Million)
Table 45 Asia Pacific single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 46 Asia Pacific single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 47 Asia Pacific single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 48 Japan single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 49 Japan single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 50 Japan single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 51 China single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 52 China single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 53 China single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 54 India single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 55 India single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 56 India single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 57 Australia single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 58 Australia single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 59 Australia single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 60 Thailand single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 61 Thailand single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 62 Thailand single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 63 South Korea single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 64 South Korea single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 65 South Korea single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 66 Latin America single-cell omics market, by country, 2018 - 2030 (USD Million)
Table 67 Latin America single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 68 Latin America single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 69 Latin America single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 70 Brazil single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 71 Brazil single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 72 Brazil single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 73 Mexico single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 74 Mexico single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 75 Mexico single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 76 Argentina single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 77 Argentina single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 78 Argentina single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa single-cell omics market, by country, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 83 South Africa single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 84 South Africa single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 85 South Africa single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 89 UAE single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 90 UAE single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 91 UAE single-cell omics market, by end-user, 2018 - 2030 (USD Million)
Table 92 Kuwait single-cell omics market, by product type, 2018 - 2030 (USD Million)
Table 93 Kuwait single-cell omics market, by application, 2018 - 2030 (USD Million)
Table 94 Kuwait single-cell omics market, by end-user, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 single-cell omics market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 PESTEL analysis
Fig. 13 Porter’s five forces analysis
Fig. 14 Global single-cell omics market: Product type movement analysis
Fig. 15 Global single-cell omics market, for single-cell genomics, 2018 - 2030 (USD Million)
Fig. 16 Global single-cell omics market, for single-cell transcriptomics, 2018 - 2030 (USD Million)
Fig. 17 Global single-cell omics market, for single-cell proteomics, 2018 - 2030 (USD Million)
Fig. 18 Global single-cell omics market, for single-cell metabolomics, 2018 - 2030 (USD Million)
Fig. 19 Global single-cell omics market: Application movement analysis
Fig. 20 Global single-cell omics market, for oncology, 2018 - 2030 (USD Million)
Fig. 21 Global single-cell omics market, for cell biology, 2018 - 2030 (USD Million)
Fig. 22 Global single-cell omics market, for neurology, 2018 - 2030 (USD Million)
Fig. 23 Global single-cell omics market, for immunology, 2018 - 2030 (USD Million)
Fig. 24 Global single-cell omics market: End-user movement analysis
Fig. 25 Global single-cell omics market, for academic and research organizations, 2018 - 2030 (USD Million)
Fig. 26 Global single-cell omics market, for pharmaceutical & biotechnology companies, 2018 - 2030 (USD Million)
Fig. 27 Global single-cell omics market, for hospital and diagnostic laboratories, 2018 - 2030 (USD Million)
Fig. 28 Global single-cell omics market, for others, 2018 - 2030 (USD Million)
Fig. 29 Regional marketplace: Key takeaways
Fig. 30 Regional outlook, 2022 & 2030
Fig. 31 Global single-cell omics market: Region movement analysis
Fig. 32 North America single-cell omics market, 2018 - 2030 (USD Million)
Fig. 33 U.S. single-cell omics market, 2018 - 2030 (USD Million)
Fig. 34 Canada single-cell omics market, 2018 - 2030 (USD Million)
Fig. 35 Europe single-cell omics market, 2018 - 2030 (USD Million)
Fig. 36 Germany single-cell omics market, 2018 - 2030 (USD Million)
Fig. 37 UK single-cell omics market, 2018 - 2030 (USD Million)
Fig. 38 France single-cell omics market, 2018 - 2030 (USD Million)
Fig. 39 Italy single-cell omics market, 2018 - 2030 (USD Million)
Fig. 40 Spain single-cell omics market, 2018 - 2030 (USD Million)
Fig. 41 Denmark single-cell omics market, 2018 - 2030 (USD Million)
Fig. 42 Sweden single-cell omics market, 2018 - 2030 (USD Million)
Fig. 43 Norway single-cell omics market, 2018 - 2030 (USD Million)
Fig. 44 Asia Pacific single-cell omics market, 2018 - 2030 (USD Million)
Fig. 45 Japan single-cell omics market, 2018 - 2030 (USD Million)
Fig. 46 China single-cell omics market, 2018 - 2030 (USD Million)
Fig. 47 India single-cell omics market, 2018 - 2030 (USD Million)
Fig. 48 Australia single-cell omics market, 2018 - 2030 (USD Million)
Fig. 49 South Korea single-cell omics market, 2018 - 2030 (USD Million)
Fig. 50 Thailand single-cell omics market, 2018 - 2030 (USD Million)
Fig. 51 Latin America single-cell omics market, 2018 - 2030 (USD Million)
Fig. 52 Brazil single-cell omics market, 2018 - 2030 (USD Million)
Fig. 53 Mexico single-cell omics market, 2018 - 2030 (USD Million)
Fig. 54 Argentina single-cell omics market, 2018 - 2030 (USD Million)
Fig. 55 Middle East and Africa single-cell omics market, 2018 - 2030 (USD Million)
Fig. 56 South Africa single-cell omics market, 2018 - 2030 (USD Million)
Fig. 57 Saudi Arabia single-cell omics market, 2018 - 2030 (USD Million)
Fig. 58 UAE single-cell omics market, 2018 - 2030 (USD Million)
Fig. 59 Kuwait single-cell omics market, 2018 - 2030 (USD Million)

Companies Mentioned

  • CYTENA GmbH
  • 10x Genomics
  • BD
  • CELLENION
  • PerkinElmer Inc.
  • ANGLE plc
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • Mission Bio
  • Standard BioTools Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Single-Cell Omics Global Market Report 2024 - Product Image

Single-Cell Omics Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Multiomics Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables), By Type (Single-cell, Bulk), By Platform, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Multiomics Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables), By Type (Single-cell, Bulk), By Platform, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
U.S. Multiomics Market Size, Share & Trends Analysis Report by Product & Service (Instruments, Consumables), Type (Single-cell, Bulk), Platform, Application, End-use, and Segment Forecasts, 2024-2030 - Product Image

U.S. Multiomics Market Size, Share & Trends Analysis Report by Product & Service (Instruments, Consumables), Type (Single-cell, Bulk), Platform, Application, End-use, and Segment Forecasts, 2024-2030

  • Report
  • 90 Pages
  • United States
From
Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part B. International Review of Cell and Molecular Biology Volume 392 - Product Image

Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part B. International Review of Cell and Molecular Biology Volume 392

  • Book
  • Global
Single-Cell Omics. Volume 2: Technological Advances and Applications - Product Image

Single-Cell Omics. Volume 2: Technological Advances and Applications

  • Book
Copyright © 2002-2024 Research and Markets. All Rights Reserved.